UK markets closed
NIKKEI 225
27,772.93 +305.70 (+1.11%) HANG SENG
24,952.35 +824.50 (+3.42%) CRUDE OIL
86.29 -0.61 (-0.70%) GOLD FUTURES
1,839.70 -2.90 (-0.16%) DOW
34,715.39 -313.26 (-0.89%) BTC-GBP
30,093.83 -895.24 (-2.89%)
Arbutus Biopharma Corporation (0SGC.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:16PM GMT
| Previous close | 3.0550 |
| Open | 2.9760 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 2.9450 - 2.9980 |
| 52-week range | 2.9450 - 2.9980 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 2.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9170 |
| Earnings date | 02 Mar 2022 - 07 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Do Options Traders Know Something About Arbutus Biopharma (ABUS) Stock We Don't?
Investors need to pay close attention to Arbutus Biopharma (ABUS) stock based on the movements in the options market lately.
- Simply Wall St.
Here's Why We're Not Too Worried About Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Zacks
Anixa (ANIX) COVID Compounds Prove Effective Against Omicron
Anixa Biosciences' (ANIX) potential COVID-19 compounds show effectiveness against the Omicron variant of COVID-19.
© 2022 Yahoo. All rights reserved.
